T. Rowe Price Health Sciences Fund I Class
Limited financial coverage for THISX.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
The fund's primary objective is to achieve long-term capital appreciation. To meet this goal, it typically invests at least 80% of its net assets (including any assets acquired through borrowing) in the common stocks of companies within the broad "health sciences" sector. This includes firms involved in the research, development, production, or distribution of products and services related to healthcare, medicine, or life sciences.
- IPO
- 2016
- HQ
- Baltimore, MD, US
Get TickerSpark's AI analysis on THISX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $12.40B
- Div Yield
- 10.97%
- 52W High
- $99.29
- 52W Low
- $75.40
- 50D MA
- $94.52
- 200D MA
- $85.94
- Beta
- 0.66
- RSI (14)
- 43
- Avg Volume
- 0
No earnings-call transcripts are available for THISX yet.
- Free Float
- 0.0%
- Shares Outstanding
- 133.50M
- Float Shares
- 0
Our THISX coverage
Recent articles, reports, and earnings notes.
No research on THISX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate THISX report →